New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
about
Evidence and implications of mortality associated with acute Plasmodium vivax malariaA long neglected world malaria map: Plasmodium vivax endemicity in 2010Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquineArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malariaArtemisinin-based combination therapy for the treatment of uncomplicated Plasmodium vivax malaria and the prevention of relapsesArtemisinin combination therapy for vivax malariaGenetic polymorphisms linked to susceptibility to malariaMalaria-related anaemia: a Latin American perspectiveUsing genetic methods to define the targets of compounds with antimalarial activityThe anaemia of Plasmodium vivax malariaTargeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working GroupThe role of animal models for research on severe malariaPfCRT and its role in antimalarial drug resistanceBiosynthesis of GDP-fucose and other sugar nucleotides in the blood stages of Plasmodium falciparumFrom within host dynamics to the epidemiology of infectious disease: Scientific overview and challengesEpidemiology of Plasmodium vivax Malaria in PeruA systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquitoThe use of artemether-lumefantrine for the treatment of uncomplicated Plasmodium vivax malariaAn analytical method for assessing stage-specific drug activity in Plasmodium vivax malaria: implications for ex vivo drug susceptibility testingReduced risk of Plasmodium vivax malaria in Papua New Guinean children with Southeast Asian ovalocytosis in two cohorts and a case-control studyDeoxyhypusine hydroxylase from Plasmodium vivax, the neglected human malaria parasite: molecular cloning, expression and specific inhibition by the 5-LOX inhibitor zileutonTheoretical and experimental studies of new modified isoflavonoids as potential inhibitors of topoisomerase I from Plasmodium falciparumGlobal Epidemiology of Plasmodium vivaxDiffering patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.Effective preparation of Plasmodium vivax field isolates for high-throughput whole genome sequencingThe Vivax Surveyor: Online mapping database for Plasmodium vivax clinical trialsA 95 kDa protein of Plasmodium vivax and P. cynomolgi visualized by three-dimensional tomography in the caveola-vesicle complexes (Schüffner's dots) of infected erythrocytes is a member of the PHIST familyA systematic review of the clinical presentation, treatment and relapse characteristics of human Plasmodium ovale malariaUnderstanding the clinical spectrum of complicated Plasmodium vivax malaria: a systematic review on the contributions of the Brazilian literatureClinical and epidemiological profiles of severe malaria in children from Delhi, India.Thrombotic microangiopathy and acute kidney injury following vivax malaria.Severe and complicated Plasmodium vivax malaria in children.Malaria in childrenPlasmodium ovale: a case of not-so-benign tertian malariaPlatelet profile is associated with clinical complications in patients with vivax and falciparum malaria in Colombia.A descriptive study of 16 severe Plasmodium vivax cases from three municipalities of Colombia between 2009 and 2013.Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malariaCharacteristics of Travel-Related Severe Plasmodium vivax and Plasmodium falciparum Malaria in Individuals Hospitalized at a Tertiary Referral Center in Lima, Peru.Laboratory Diagnosis of Malaria: Comparison of Manual and Automated Diagnostic Tests.
P2860
Q21032494-685B9BAE-352E-45B7-A29D-899DAB50E914Q21144495-30492B20-8497-449C-8484-4DA76B69AE59Q24202900-EAA97600-C532-4DE8-B5B4-510A515E541EQ24202910-3380C647-3B13-4F68-BE5D-713D8825E1FCQ24235351-80B57401-E050-4AA9-90E8-CEF6C0DDD5E9Q24236067-C3574F9A-12D7-4A88-99CD-43208156E2C7Q24622539-7D6A2FAB-566E-48B1-910F-847995C5BFF8Q26860744-93C0062D-CDF9-44FE-996B-10BFA7AE976CQ26997119-8FF32CA9-7AC7-4C1D-B948-F0FBB6B89A6FQ27014788-70169FF6-7FCE-4DFE-9C6E-DB751EC3A3FBQ27026970-19D4A7EC-096C-494C-906C-14ECA0F84F8FQ27304660-9B3ED465-0AA1-481C-B7BC-303BF09FB7C1Q27348351-65382ED1-C88C-4E88-9C4F-602A12E6B920Q27861957-833D0194-042F-47F2-9446-E9D792DA8E60Q27973031-C5BF8202-777E-4ACF-97CF-574583C3BB72Q28087108-2DF3A1DC-C520-4698-AD1D-205E7932AA72Q28355360-2D564B14-06B7-4E2B-BBE5-F708B795197FQ28473572-E7ECB5C6-AF19-430D-A810-435458879DB2Q28478579-B5115956-6CAB-447D-8E42-444E9378B5C9Q28482113-6BDCF7BE-D9A8-4724-89B8-8C733FF7C0C7Q28483318-07D88A29-BDFE-4E68-AF56-A651C772A69DQ28487727-2E0DDB5B-5D39-443D-8D2C-854F7C2D9EDBQ28541220-AEFD0C1A-9D4D-45BE-A55D-7314D6BB7163Q30249044-29E29600-876C-4955-9D70-602AA234E98EQ30439881-78F80726-FE3E-434D-BF80-8B06BEB5CF33Q30459215-18B581A0-C0B0-4AB2-86EF-27298F35ADC1Q30491343-52819237-17A3-4E28-A6AE-C9E5F0A3A289Q30514204-F2F3A797-08C7-4FDA-BABE-5ED1F4F91369Q30841521-89F4D7B9-CC2C-4D98-B882-CDBE69AA004FQ33399080-C070445B-B556-4E44-BBA5-4F2DC0F94623Q33400863-C50FD4B6-F198-4018-91A3-29CF7274ABFDQ33402100-5F0EF52C-CF9D-4260-B4B9-E7BF675AF069Q33402665-5B16B382-32AB-4A22-A924-1D0967447901Q33404647-EDEC436D-DA51-478D-ABFF-E1C4990126D4Q33413808-1B18FAD7-CC0F-47CB-9402-01EAC05D2A58Q33416808-26A2FEC1-1997-4111-8F5F-5E40689D665DQ33418215-35E060D8-66AB-45E3-89F9-4C6AA89221BCQ33419656-6CB9E089-BCE7-4078-93A9-9F3231F3EDA3Q33426858-D015C2EC-5664-4295-AB9B-82F387D02894Q33578645-6B325992-410C-485A-9DE4-D2ADDE8387D4
P2860
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
New developments in Plasmodium ...... ise of chloroquine resistance.
@ast
New developments in Plasmodium ...... ise of chloroquine resistance.
@en
type
label
New developments in Plasmodium ...... ise of chloroquine resistance.
@ast
New developments in Plasmodium ...... ise of chloroquine resistance.
@en
prefLabel
New developments in Plasmodium ...... ise of chloroquine resistance.
@ast
New developments in Plasmodium ...... ise of chloroquine resistance.
@en
P50
P921
P1476
New developments in Plasmodium ...... ise of chloroquine resistance.
@en
P304
P356
10.1097/QCO.0B013E32832F14C1
P577
2009-10-01T00:00:00Z